Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.11B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$317M |
| 3 |
Linde
LIN
|
+$290M |
| 4 |
Danaher
DHR
|
+$275M |
| 5 |
Home Depot
HD
|
+$246M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$732M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$731M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$574M |
| 4 |
Meta Platforms (Facebook)
META
|
+$573M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$484M |
Sector Composition
| 1 | Financials | 16.4% |
| 2 | Technology | 14.23% |
| 3 | Healthcare | 12.49% |
| 4 | Industrials | 10.09% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Nuvectis Pharma
NVCT
$157M
| $1.18M | ﹤0.01% |
121,101
+91,403
| +308% | +$893K |
|
2777
First Internet Bancorp
INBK
$212M
| $1.18M | ﹤0.01% |
44,122
+10,348
| +31% | +$277K |
|
2778
Candel Therapeutics
CADL
$263M
| $1.18M | ﹤0.01% |
208,609
+176,983
| +560% | +$1,000K |
|
|
KRON
2779
DELISTED
Kronos Bio
KRON
| $1.18M | ﹤0.01% |
1,425,065
-291,436
| -17% | -$240K |
|
2780
Abacus Life
ABL
$628M
| $1.17M | ﹤0.01% |
156,742
-35,277
| -18% | -$264K |
|
2781
Green Brick Partners
GRBK
$3.21B
| $1.17M | ﹤0.01% |
20,054
-26,902
| -57% | -$1.57M |
|
2782
Interface
TILE
$1.66B
| $1.17M | ﹤0.01% |
58,762
-3,547
| -6% | -$70.4K |
|
2783
Anika Therapeutics
ANIK
$125M
| $1.17M | ﹤0.01% |
77,548
+52,045
| +204% | +$782K |
|
2784
Goldman Sachs BDC
GSBD
$1.3B
| $1.16M | ﹤0.01% |
99,675
+43,364
| +77% | +$504K |
|
2785
Horizon Bancorp
HBNC
$833M
| $1.15M | ﹤0.01% |
76,578
+6,158
| +9% | +$92.9K |
|
|
TSSI
2786
TSS, Inc. Common Stock
TSSI
$454M
| $1.15M | ﹤0.01% |
+146,613
| New | +$1.15M |
|
2787
Synchronoss Technologies
SNCR
$66.9M
| $1.15M | ﹤0.01% |
105,498
+89,742
| +570% | +$977K |
|
2788
Metals Acquisition
MTAL
$1.01B
| $1.15M | ﹤0.01% |
120,232
-1,907,841
| -94% | -$18.2M |
|
2789
Telefônica Brasil
VIV
$20B
| $1.15M | ﹤0.01% |
131,475
-460,759
| -78% | -$4.02M |
|
2790
Canadian Solar
CSIQ
$729M
| $1.14M | ﹤0.01% |
132,251
+121,307
| +1,108% | +$1.05M |
|
2791
Redwire
RDW
$1.25B
| $1.14M | ﹤0.01% |
137,876
-377,268
| -73% | -$3.13M |
|
2792
EPR Properties
EPR
$4.45B
| $1.14M | ﹤0.01% |
21,698
-557,297
| -96% | -$29.3M |
|
2793
Cantaloupe
CTLP
$792M
| $1.14M | ﹤0.01% |
+144,976
| New | +$1.14M |
|
|
INZY
2794
DELISTED
Inozyme Pharma
INZY
| $1.13M | ﹤0.01% |
1,244,722
-637,552
| -34% | -$580K |
|
2795
CuriosityStream
CURI
$281M
| $1.13M | ﹤0.01% |
422,454
+366,941
| +661% | +$983K |
|
2796
Chegg
CHGG
$167M
| $1.13M | ﹤0.01% |
1,770,436
-103,722
| -6% | -$66.3K |
|
2797
GSK
GSK
$82.2B
| $1.13M | ﹤0.01% |
29,189
-62,374
| -68% | -$2.42M |
|
2798
Northrim BanCorp
NRIM
$504M
| $1.12M | ﹤0.01% |
15,341
+8,308
| +118% | +$608K |
|
2799
RPC Inc
RES
$986M
| $1.12M | ﹤0.01% |
204,117
+516
| +0.3% | +$2.84K |
|
2800
New Fortress Energy
NFE
$373M
| $1.12M | ﹤0.01% |
135,049
+52,969
| +65% | +$440K |
|